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of 100 patients in 2nd group, and 7 patients out of 100
patients in 3rd group developed atrial fibrillation.
Conclusion: Combination of B-blocker with ascorbic acid
& statin is better than B-blocker alone in reduction of
atrial fibrillation after CABG in early post operative
period.
http://dx.doi:10.1016/j.jsha.2015.05.183
3. The impact of elevated HbA1c on Surgical Site
Infection and other infectious morbidities after
isolated coronary artery bypass surgery
Ahmed A-Arifi, Muhanad Algadheeb, Munir
Ahmad, Hind Al Modaimegh, Rawdene Van
Onselen, Hani K. Najm
Background & Aim of the study: Wound infection is an
important cause of morbidity and mortality after coro-
nary artery bypass surgery (CABG). Patients with dia-
betes represent a high risk group for patients
undergoing CABG. Glycosylated hemoglobin (HbA1c),
a measure of hyperglycemia, is a sensitive and reliable
marker of impaired glucose metabolism. The aim of the
study is to compare the impact of the elevated (HbA1c),
on the post-operative risk of Surgical Site Infection
(SSI) and other infectious morbidities and mortality after
isolated CABG.
Patients & methods: Two hundred and fifty patients (190
males, 65 females; mean age 62.69 ± 11.00; range 38–
85 years) who underwent coronary artery bypass sur-
gery at our center between January and December
2012 were enrolled in this study. All patients including
the non-diabetics were managed with a specialized
hospital protocol for glycemic control in the periopera-
tive period.
Results: Out of the 255 patients, 169 patients (66.3%) had
elevated preoperative HbA1c and 183 (71.8%), were dia-
betics. Surgical Site infection were observed in 26
patients with elevated HbA1c and 2 patients in the nor-
mal HbA1c group respectively (15. 3% vs 3.6%,
p = 0.002), Pneumonia, were observed in 11 in the ele-
vated and 3 in the normal HbA1c respectively (6.5% vs
5.5%), Furthermore, Septicemia was observed in 3
patients (1.8%) with elevated HbA1c. The 30 days mortal-
ity was Zero in both groups.
Conclusion: Our cohorts of patients have a high incidence
of diabetes, and 66.3% of the patients have elevated HbA1c
at the time of surgery. Patients with elevated HbA1c,
undergoing isolated coronary artery bypass surgery have
a significantly higher risk of surgical site infection and
may have a higher risk of other infectious complications,
but have no impact on early mortality.
http://dx.doi:10.1016/j.jsha.2015.05.184
4. Comparing risk factors profile in patients with
Coronary Artery Disease who underwent cardiac
catheterization with those revealed to have normal
coronary arteries: A case-control study
Maha Mohammed Aldohan, Abdullah Khalid
Aljohany, Hanaa O. Salamah, Ahmed Alsaileek
Introduction: Coronary Artery Disease (CAD) is one of
the major causes of morbidity and a leading public health
issue, comprising the death causes of millions of men and
women worldwide. Most of prior studies in the region of
the modifiable risk factors were cross-sectional studies.
Objectives: Study was conducted to compare those who
revealed to have CAD after cardiac catheterization with
those who shown to be free from CAD. The comparison
planned based on the following variables: age, gender,
Body Mass Index (BMI), smoking, hypertension, dyslipi-
demia, diabetes mellitus, and the presence or absence of
family history of CAD, in order to identify significant risk
factors of CAD in our population. Second objective was to
identify the most important predictors for CAD, in order
to help clinicians identifying main characteristics of a car-
diac cath candidate in our population.
Methods: A case-control study was conducted by extract-
ing data of patients who underwent cardiac cath between
10th of June 2008 and 8 July 2013. Patients’ information
was taken from King Abdulaziz Cardiac Center in
Riyadh (KACC) catheterization lab with the following
inclusion and exclusion criteria:
 Inclusion criteria: Age >18, both genders, suspected to
have CAD and had at least one visit prior to
catheterization.
 Exclusion criteria: other cardiac diseases including
valvular disease, vacuities, congenital anomalies,
and cath done not primarily to rule out CAD
Sample size was calculated based on presence of fam-
ily history with estimated proportion of 0.048 in controls,
odd ratio of 3, 95% confidence level and 90% power to be
484 subjects in total (with a case to control ratio of 1:1, 242
for each group). The sample size then was maximized to
include all patient who were found not having CAD after
heart cath (total of 456 for control group), cases (those
found to have CAD) were minimized to 456 subjects
through computerized based simple random sampling
technique. Data was recorded in data collection sheet
based on subjects’ disease status (diseased, or not dis-
eased), and their exposure to single or multiple factors.
Results: Total of 912 subjects included in the analysis, 456
for each group. The mean was 58.52 ± 13, and the mean
BMI was 29.8 ± 6. Smoker were 25.5%, those with hyper-
tension were 58%. Hyperlipidemia was experienced in
49%, diabetes in 50.7% of subjects. Family history of
CAD presented in 4.8% of total subject who went for car-
diac cath. All expected risk factors entered in the logistic
regression analysis, and showed significantly different
prevalence in patients with CAD compared to those with-
out; gender (P < 0.001),diabetes (P < 0.001),age (P < 0.001),
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BMI (P < 0.001), dyslipidaemia (P < 0.001), smoking
(P = 0.017), family history (P = 0.994) and hypertension
with P < 0.001.
Conclusion: The most important predictors of CAD in our
population were age, gender, BMI, dyslipidaemia, dia-
betes mellitus and smoking. Whereas, family history
was not recognized as predictor, this is may be due impro-
per documentation of this variable in patient records.
http://dx.doi:10.1016/j.jsha.2015.05.185
5. Newly developed atrial fibrillation in liver
transplant patient with intravenous dexmedeto-
medine sedation
Adel Hammodi Ali, Ali Al-Azim
Introduction: Atrial fibrillation (AF) is the commonest type
of arrhythmias in common population and critically ill as
well. Intensive care patients are vulnerable to develop AF
due to numerous causing and risk factors during their ill-
ness. Drug-induced AF is a group of underestimated
causes known to induce arrhythmias in severely ill
patients one of these medications is. Dexmetedomedine
(precedx) one of relatively new sedative-analgesic is effec-
tively used in mechanically ventilated patients and as a
consequence recent critical care society recommendations
claimed dexmedetomidine may be preferred over seda-
tion with benzodiazepines.
Case report: We present a case report of newly devel-
oped resistant AF in post living-related liver transplant
lady who received intravenous dexmedetomidine as
recommended sedative to liberate her from the
ventilator.
Discussion: Despite the presence of other clinical risk
factors pertinent to the patient to develop AF which
took place after starting dexmedetomidine, yet the res-
olution of AF had occurred subsequent to cessation of
dexmedetomidine. Retrospective analysis of critical care
department database of king Fahad specialist hospital
Dammam from January 2011 till July 2014 up to
revealed about 20% of patients received intravenous
dexmedetomidine had experienced AF. In fact these
results are higher than the reported information by
the literature.
Conclusion: Intravenous dexmedetomidine (precedex) is
a common cause of AF in critically ill patients. This kind
of side effect needs scrutinized assessment and follow up
to find out the risk factors involved in its development
especially in the era of increasing dexmedetomidine as
a state-of-art recommended sedative agent in intensive
care units and perioperative as well.
http://dx.doi:10.1016/j.jsha.2015.05.186
6. Endovascular treatment for acute traumatic
transection of the thoracic aorta: The safety of
delayed stenting
Adil H. Al Kindi, Rashid Al Sukaiti, Khalifa Al
Wahibi
Objective: The current recommendation is immediate
surgical treatment of acute traumatic transection (ATT)
of the aorta. Open surgical repair carries high morbidity
and mortality. Endovascular repair (TEVAR) has
emerged as a safer option. The timing of intervention
remains a matter of debate We review our outcomes of
delayed endovascular repair of ATT.
Methods: From 2011 to 2013, 7 patients underwent
delayed TEVAR for ATT. All patients had their records
reviewed retrospectively regarding mechanism of injury,
concomitant injuries, technical details, post-operative
complications and long term follow up.
Results: The mean age was 30.29 years (range 24–
51 years) and 6 out of 7 patients were male. The mecha-
nism of injury was motor vehicle collision in 6 patients.
The median time from injury to TEVAR was 8.7 days
and there was no mortality during this period.
Technical success was 100%. None of the patients suf-
fered any neurological events, arrhythmias, acute renal
injury, distal ischemia or endoleak. The median hospital
stay was 10 days and all patients were discharged home
with no hospital mortality. Mean follow up was
12 months and all patients were alive at follow up and
none required re-intervention.
Conclusion: The delayed approach has been safe with no
patients lost during the waiting period. Patients with ATT
who make it to the hospital and are stable from the
aortic point of view may be managed safely with
delayed TEVAR if immediate therapy is not available or
possible.
http://dx.doi:10.1016/j.jsha.2015.05.187
7. Septal myectomy for hypertrophic obstructive
cardiomyopathy in the young adults and children
Salah Eldien Altarabsheh, Salil Deo, Joseph
Dearani, Hartzell Schaff
Purpose: Hypertrophic obstructive cardiomyopathy
(HOCM) is one of the leading causes for heart failure in
the young; few studies were published the results of sur-
gical therapy in this age category. Our aim was to assess
the late results of basal septal myectomy in the young.
Methods: We retrospectively reviewed the records of 128
consecutive patients (38% female), age less than 21 years,
who underwent basal septal myectomy for HOCM in the
period between 1975 and 2010 at the Mayo Clinic
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